Science Explorer Back to mapMap
Discussion
Researcher · University of Massachusetts Chan Medical School · United States

Christl Gaubitz

Christl Gaubitz publishes mostly in Molecular Biology, Pharmacology and Ecology, on topics such as DNA Repair Mechanisms, CRISPR and Genetic Engineering and RNA Research and Splicing.

ORCID 0000-0002-6047-9282 OpenAlex
World rank
#1,944,387
of 7,710,434 ranked researchers
Rank in United States
#592,303
of 1,627,098
Works
24
Citations
662
Citations per work
27.6
h-index
10
i10-index 10Top 76% in Molecular Biology
Christl Gaubitz

What does Christl Gaubitz research?

Christl Gaubitz's work is mostly in Biochemistry, Genetics and Molecular Biology (77%), Medicine (5%), Agricultural and Biological Sciences (3%).

Life Sciences: 20 works · 83.3% of their workBiochemistry, Genetics and Molecular Biology: 18 works · 76.7% of their workMolecular Biology: 18 works · 75.0% of their workGenetics: 0 works · 1.7% of their workAgricultural and Biological Sciences: 1 works · 3.3% of their workEcology, Evolution, Behavior and Systematics: 1 works · 3.3% of their workNeuroscience: 1 works · 3.3% of their workCellular and Molecular Neuroscience: 1 works · 3.3% of their workEverything else: 2 works · 8.4% of their workHealth Sciences: 1 works · 5.0% of their workMedicine: 1 works · 5.0% of their workPharmacology: 1 works · 5.0% of their workPhysical Sciences: 1 works · 3.3% of their workEnvironmental Science: 1 works · 3.3% of their workEcology: 1 works · 3.3% of their workTHEIR WORKChristl Gaubitz24works
Life Sciences83%Physical Sciences3%Health Sciences5%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1876.7%
    2. Agricultural and Biological Sciences13.3%
    3. Neuroscience13.3%
  2. Everything else28.4%
    1. Medicine15.0%
    1. Environmental Science13.3%
  1. 1Molecular Biology75% of their works
  2. 2Pharmacology5% of their works
  3. 3Ecology3% of their works
  4. 4Cellular and Molecular Neuroscience3% of their works
  5. 5Ecology, Evolution, Behavior and Systematics3% of their works
  6. 6Genetics2% of their works

Research topics

Which keywords describe Christl Gaubitz's research?

The keywords of their largest research topics: Cancer, DNA Damage, Repair, Cancer Therapy, Alternative Splicing, Genome Engineering, mTOR and RNA-Binding Proteins.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Cancer142 topics
  2. DNA Damage91 topic
  3. Repair91 topic
  4. Cancer Therapy62 topics
  5. Alternative Splicing51 topic
  6. Genome Engineering51 topic
  7. RNA-Binding Proteins51 topic
  8. RNA-Guided51 topic
  9. Signaling51 topic
  10. mTOR51 topic
  11. Genomics41 topic
  12. Yeast41 topic
  13. Antioxidant Activity31 topic
  14. Medicinal Mushrooms31 topic
  15. Protein Kinases31 topic
  16. Ras Signaling31 topic
  17. Ribosome31 topic
  18. Translation31 topic

Where does Christl Gaubitz work?

Christl Gaubitz's main affiliation in the publication record is University of Massachusetts Chan Medical School, United States.

How many publications and citations does Christl Gaubitz have?

OpenAlex counts 24 works and 662 citations for Christl Gaubitz, an h-index of 10, ranking #1,944,387 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christl Gaubitz. Posts are plain text and can be reported.